Person Prof Danny Rischin National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK trial (funded by National Health and Medical Research Council) Principal investigator of A randomized trial of radiation with cetuximab or weekly cisplatin in low risk locoregionally advanced HPV-associated oropharyngeal cancer (funded by National Health and Medical Research Council) Participant in Molecular classification of carcinoma of unknown primary (funded by National Health and Medical Research Council) Participant in Post-operative concurrent chemo-radiotherapy versus post-operative radiotherapy in high risk cutaneous squamous cell carcinoma of the head and neck (POST Study) TROG 05.01 (funded by National Health and Medical Research Council) Principal investigator of Predictive significance of tumor hypoxia in patients with head and neck cancer treated on a randomized trial (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK trial (funded by National Health and Medical Research Council) Principal investigator of A randomized trial of radiation with cetuximab or weekly cisplatin in low risk locoregionally advanced HPV-associated oropharyngeal cancer (funded by National Health and Medical Research Council) Participant in Molecular classification of carcinoma of unknown primary (funded by National Health and Medical Research Council) Participant in Post-operative concurrent chemo-radiotherapy versus post-operative radiotherapy in high risk cutaneous squamous cell carcinoma of the head and neck (POST Study) TROG 05.01 (funded by National Health and Medical Research Council) Principal investigator of Predictive significance of tumor hypoxia in patients with head and neck cancer treated on a randomized trial (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
